Colorectal cancer is one of the most common types of cancer in Ukraine. Prognosis for patients with peritoneal carcinomatosis is unfavorable, and life expectancy is typically less than 6 months. Cytoreductive surgery was introduced as a new method of treating these patients to prolong their survival time.The objective of the research was to evaluate and compare the efficacy of cytoreductive surgery, chemotherapy and symptomatic treatment of patients with colorectal cancer and peritoneal carcinomatosis.Materials and methods. The research included 93 patients with colorectal cancer and peritoneal carcinomatosis. All patients were divided into 3 groups depending on the method of treatment being used after the detection of peritoneal carcinomat...
Compared with intravenous chemotherapy, cytoreductive surgery (CRS) and hyperthermic intraperitoneal...
SummaryIntroductionCompared with intravenous chemotherapy, cytoreductive surgery (CRS) and hyperther...
Background: Today, we do not have a universally accepted evidence on how to treat peritoneal carcino...
Peritoneal carcinomatosis (PC) in contrast to lymph nodes and liver metastases was assumed as a term...
Purpose: To present our clinical experience on the combined (surgicochemotherapeutic) treatment of p...
Background: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIP...
The incidence of peritoneal carcinomatosis of colorectal cancer amounts to 5%-15% for synchronous me...
Background: Advanced colorectal cancer (CRC) is prone to developing peritoneal carcinomatosis (PC). ...
A multicentric prospective study has been carried on 69 patients affected by peritoneal carcinomatos...
Peritoneal carcinomatosis (PC) is a difficult clinical challenge in colorectal cancer (CRC) because ...
BACKGROUND AND STUDY AIM: Over the last 20 years, cytoreductive surgery (CRS) combined with hyperthe...
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal car...
BACKGROUND:Peritoneal carcinomatosis (PC) is a difficult clinical challenge in colorectal cancer (CR...
Peritoneal carcinomatosis (PC) is a common evolution of cancer of the gastrointestinal tract, and ha...
Background Cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) treatment of colorecta...
Compared with intravenous chemotherapy, cytoreductive surgery (CRS) and hyperthermic intraperitoneal...
SummaryIntroductionCompared with intravenous chemotherapy, cytoreductive surgery (CRS) and hyperther...
Background: Today, we do not have a universally accepted evidence on how to treat peritoneal carcino...
Peritoneal carcinomatosis (PC) in contrast to lymph nodes and liver metastases was assumed as a term...
Purpose: To present our clinical experience on the combined (surgicochemotherapeutic) treatment of p...
Background: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIP...
The incidence of peritoneal carcinomatosis of colorectal cancer amounts to 5%-15% for synchronous me...
Background: Advanced colorectal cancer (CRC) is prone to developing peritoneal carcinomatosis (PC). ...
A multicentric prospective study has been carried on 69 patients affected by peritoneal carcinomatos...
Peritoneal carcinomatosis (PC) is a difficult clinical challenge in colorectal cancer (CRC) because ...
BACKGROUND AND STUDY AIM: Over the last 20 years, cytoreductive surgery (CRS) combined with hyperthe...
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal car...
BACKGROUND:Peritoneal carcinomatosis (PC) is a difficult clinical challenge in colorectal cancer (CR...
Peritoneal carcinomatosis (PC) is a common evolution of cancer of the gastrointestinal tract, and ha...
Background Cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) treatment of colorecta...
Compared with intravenous chemotherapy, cytoreductive surgery (CRS) and hyperthermic intraperitoneal...
SummaryIntroductionCompared with intravenous chemotherapy, cytoreductive surgery (CRS) and hyperther...
Background: Today, we do not have a universally accepted evidence on how to treat peritoneal carcino...